Table 1.
Control group (n = 152) | Aspirin group (n = 118) | P value | |
---|---|---|---|
Gender (female/male) | 81/71 | 62/56 | 1.00 |
Age (year) | 60.17 ± 10.56 | 64.31 ± 7.96 | <0 . 001 |
LBP history (month) | 40.98 ± 62.51 | 48.55 ± 65.15 | 0.333 |
Alcohol consumption | 62 | 52 | 0.677 |
Smoking | 64 | 52 | 0.842 |
BMI (kg/m2) | 25.97 ± 3.54 | 25.79 ± 3.4 | 0.669 |
VAS | 5.56 ± 1.76 | 6.08 ± 1.72 | 0.015 |
CCI | 1.94 ± 0.97 | 2.19 ± 1.07 | 0.043 |
LBP, low back pain; BMI, body mass index; VAS, visual analogue scale; CCI, Charlson Comorbidity Index; PSM, Propensity Score Matching.
Italics indicate statistically significant differences.